Showing results (1401-1410 of 4,565) with videos related to

Sort By:
Pageof 457
Advances in Therapy|October 20, 2022
Cost-Effectiveness of Acthar Gel Versus Standard of Care for the Treatment of Exacerbations in Moderate-to-Severe Systemic Lupus ErythematosusJas Bindra, Ishveen Chopra, Kyle Hayes, et al.
Advances in Therapy|November 1, 2022
No Increased Risk of Overall Infection in Adults with Moderate-to-Severe Atopic Dermatitis Treated for up to 4 Years with DupilumabAndrew Blauvelt, Andreas Wollenberg, Lawrence F Eichenfield, et al.
Advances in Therapy|July 15, 2015
Safety and Tolerability of Fingolimod in Latin American Patients with Relapsing-Remitting Multiple Sclerosis: The Open-Label FIRST LATAM StudyLaura Ordoñez-Boschetti, Roberto Rey, Ana Cruz, et al.
Advances in Therapy|September 3, 2025
Real-World Outcomes with Orelabrutinib in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Retrospective StudyZi Wang, Congwei Jia, Xuan Wang, et al.
Advances in Therapy|September 4, 2025
A Review of the Utilization of Relative Dose Intensity and Dose Delay Factor in Health Technology Appraisals of Oncology Drugs in Solid TumorsAnandaroop Dasgupta, Ankita Kaushik, Shubhram Pandey, et al.
Advances in Therapy|July 20, 2016
Pharmacokinetics and Safety of Triple Therapy with Vonoprazan, Amoxicillin, and Clarithromycin or Metronidazole: A Phase 1, Open-Label, Randomized, Crossover StudyYuuichi Sakurai, Madoka Shiino, Hiroyuki Okamoto, et al.
Advances in Therapy|June 26, 2015
Daptomycin in the Clinical Setting: 8-Year Experience with Gram-positive Bacterial Infections from the EU-CORE(SM) RegistryArmando Gonzalez-Ruiz, Panayiotis Gargalianos-Kakolyris, Artur Timerman, et al.
Advances in Therapy|August 29, 2025
Emerging Concepts in Diagnosis, Pathologic Features, and Treatment of Limbic-Predominant Amnestic Neurodegenerative Syndrome (LANS): A Narrative ReviewMacie A Serio, Drew R Dethloff, Grant C Curry, et al.
Advances in Therapy|August 31, 2021
Changes in Healthcare Resource Use and Costs in Commercially Insured Insomnia Patients Initiating SuvorexantHrishikesh P Kale, Zaina P Qureshi, Ruchit Shah, et al.
Advances in Therapy|August 11, 2021
Cost-Effectiveness Analysis of Remdesivir Treatment in COVID-19 Patients Requiring Low-Flow Oxygen Therapy: Payer Perspective in TurkeyErgun Oksuz, Simten Malhan, Mustafa Sait Gonen, et al.
Pageof 457